Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05918224
What this trial is testing

Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 160
Not applicableEnded earlyNCT01549379
What this trial is testing

Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1
Not applicableStudy completedNCT03206242
What this trial is testing

Rehabilitation Outcomes in Head and Neck Survivors

Who this might be right for
Head and Neck CancerOral Cancer
Chang Gung Memorial Hospital 65
Testing effectiveness (Phase 2)UnknownNCT03591666
What this trial is testing

Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Who this might be right for
Head and Neck CarcinomaAdenocarcinomaRecurrent Disease+1 more
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 51
Testing effectiveness (Phase 2)Study completedNCT04929080
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC

Who this might be right for
Head and Neck Squamous Cell CarcinomNasopharyngeal Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 149
Not applicableStudy completedNCT07651020
What this trial is testing

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
Early research (Phase 1)Study completedNCT01332682
What this trial is testing

Resistance Training and Physical Functioning in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerPharyngeal CancerLaryngeal Cancer
University of Alabama at Birmingham 18
Not applicableUnknownNCT03700762
What this trial is testing

Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.

Who this might be right for
Thyroid Nodule
First People's Hospital of Hangzhou 300
Testing effectiveness (Phase 2)Looking for participantsNCT04870762
What this trial is testing

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Who this might be right for
Head and Neck CarcinomaMalignant Parotid Gland NeoplasmMaxillary Sinus Carcinoma+4 more
M.D. Anderson Cancer Center 119
Testing effectiveness (Phase 2)Ended earlyNCT03463161
What this trial is testing

Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
University of Chicago 2
Not applicableStudy completedNCT05979883
What this trial is testing

Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning

Who this might be right for
Cancer Head NeckCancer, HeadCancer Neck
Mayo Clinic 204
Not applicableLooking for participantsNCT06103669
What this trial is testing

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Who this might be right for
Breast CancerOligoprogressiveHead and Neck Cancer+2 more
University of California, Davis 250
Not applicableStudy completedNCT03102229
What this trial is testing

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

Who this might be right for
Cancer of the Head and NeckCancer of LungCancer of Esophagus+1 more
Montefiore Medical Center 40
Early research (Phase 1)Study completedNCT07431645
What this trial is testing

Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells

Who this might be right for
Radiation-Induced XerostomiaHead and Neck Cancer
Institute of Oncology Ljubljana 10
Testing effectiveness (Phase 2)Study completedNCT00468169
What this trial is testing

Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 110
Post-approval studies (Phase 4)WithdrawnNCT02000739
What this trial is testing

Genetically-informed Therapies for Patients With Metastatic Cancer

Who this might be right for
Metastatic Cancer
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)WithdrawnNCT02251639
What this trial is testing

Diagnostic Aids for Detection and Diagnosis of Oral Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Testing effectiveness (Phase 2)UnknownNCT03654612
What this trial is testing

Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Who this might be right for
Head and Neck Cancer
China International Medical Foundation 30
Early research (Phase 1)Ended earlyNCT00882583
What this trial is testing

Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Next Page